Investigating the Mechanisms Underlying the Pathogenesis of Alopecia Areata
May 2018
in “
White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this study, researchers found that alopecia areata patients show a significant reduction in suppressive regulatory T-cells and an increase in inflammatory T-cell populations, suggesting an immunological imbalance contributing to the disease.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the pathogenesis of alopecia areata (AA), focusing on the imbalance between regulatory T-cells (Tregs) and inflammatory T-cells (Teff), which led to immune privilege collapse and hair follicle attack. It involved 20 AA patients and 10 healthy controls, revealing a significant reduction in Tregs and an increase in activated Teff cells in AA patients. The research identified unique T-cell receptor clones in AA patients, suggesting a clonal response to specific antigens. Epigallocatechin gallate (EGCG) was proposed as a potential treatment to restore Treg-Teff balance by inhibiting the IFN-y-JAK-STAT pathway and reducing inflammatory markers. The study highlighted the complex immunological profile of hair follicles and suggested EGCG as a safer alternative to existing treatments, though further research was recommended to confirm these findings and explore therapeutic applications.
